Preservation of myocyte contractile function after hyperthermic cardioplegic arrest by activation of ATP-sensitive potassium channels

Circulation. 1997 Oct 7;96(7):2376-84. doi: 10.1161/01.cir.96.7.2376.

Abstract

Background: Left ventricular (LV) dysfunction can occur after hyperkalemic cardioplegic arrest and subsequent reperfusion and rewarming. Activation of adenosine triphosphate (ATP)-sensitive potassium (KATP) channels within the myocyte sarcolemma has been shown to be cardioprotective for myocardial reperfusion injury and ischemia and may play a contributory role in preconditioning for cardioplegic arrest. Accordingly, the present study tested the hypothesis that cardioplegic arrest and activation of KATP channels by a potassium channel opener (PCO) would attenuate alterations in ionic homeostasis and improve myocyte contractile function.

Methods and results: Porcine LV myocytes were isolated and randomly assigned to the following treatment groups: normothermic control, incubation in cell culture media for 2 hours at 37 degrees C (n=60); hyperkalemic cardioplegia, incubation for 2 hours in hypothermic hyperkalemic cardioplegic solution (n=60); or PCO/cardioplegia, incubation in cardioplegic solution containing 100 micromol/L of the PCO aprikalim (n=60). Hyperkalemic cardioplegia and rewarming caused a significant reduction in myocyte velocity of shortening compared with normothermic control values (33+/-2 versus 66+/-2 microm/s, P<.05). Cardioplegic arrest with PCO supplementation significantly improved indices of myocyte contractile function when compared with hyperkalemic cardioplegia (58+/-4 microm/s, P<.05). Myocyte intracellular calcium increased during hyperkalemic cardioplegic arrest compared with baseline values (147+/-2 versus 85+/-2 nmol/L, P<.05). The increase in intracellular calcium was significantly reduced in myocytes exposed to the PCO-supplemented cardioplegic solution (109+/-4 nmol/L, P<.05).

Conclusions: Cardioplegic arrest with simultaneous activation of KATP channels preserves myocyte contractile processes and attenuates the accumulation of intracellular calcium. These findings suggest that changes in intracellular calcium play a role in myocyte contractile dysfunction associated with cardioplegic arrest. Moreover, alternative strategies may exist for preservation of myocyte contractile function during cardioplegic arrest.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Calcium / metabolism
  • Cardioplegic Solutions*
  • Cells, Cultured
  • Heart / drug effects
  • Heart / physiology
  • Heart / physiopathology*
  • Heart Arrest, Induced*
  • Hot Temperature
  • Isoproterenol / pharmacology
  • Kinetics
  • Myocardial Contraction / drug effects*
  • Myocardial Reperfusion Injury / prevention & control
  • Myocardium / cytology
  • Picolines / pharmacology*
  • Potassium / pharmacology
  • Potassium Channels / drug effects
  • Potassium Channels / physiology*
  • Potassium Channels, Inwardly Rectifying*
  • Pyrans / pharmacology*
  • Swine
  • Time Factors
  • Vasodilator Agents / pharmacology*

Substances

  • Cardioplegic Solutions
  • Picolines
  • Potassium Channels
  • Potassium Channels, Inwardly Rectifying
  • Pyrans
  • Vasodilator Agents
  • aprikalim
  • Isoproterenol
  • Potassium
  • Calcium